229 related articles for article (PubMed ID: 33811278)
1. Multiphysics Modeling and Simulation of Subcutaneous Injection and Absorption of Biotherapeutics: Model Development.
Zheng F; Hou P; Corpstein CD; Xing L; Li T
Pharm Res; 2021 Apr; 38(4):607-624. PubMed ID: 33811278
[TBL] [Abstract][Full Text] [Related]
2. Multiphysics Modeling and Simulation of Subcutaneous Injection and Absorption of Biotherapeutics: Sensitivity Analysis.
Hou P; Zheng F; Corpstein CD; Xing L; Li T
Pharm Res; 2021 Jun; 38(6):1011-1030. PubMed ID: 34080101
[TBL] [Abstract][Full Text] [Related]
3. MPET
Wang H; Hu T; Leng Y; de Lucio M; Gomez H
Drug Deliv; 2023 Dec; 30(1):2163003. PubMed ID: 36625437
[TBL] [Abstract][Full Text] [Related]
4. Multiphysics modeling and simulation of local transport and absorption kinetics of intramuscularly injected lipid nanoparticles.
Di J; Hou P; Corpstein CD; Wu K; Xu Y; Li T
J Control Release; 2023 Jul; 359():234-243. PubMed ID: 37295730
[TBL] [Abstract][Full Text] [Related]
5. Transport and lymphatic uptake of monoclonal antibodies after subcutaneous injection.
Rahimi E; Aramideh S; Han D; Gomez H; Ardekani AM
Microvasc Res; 2022 Jan; 139():104228. PubMed ID: 34547346
[TBL] [Abstract][Full Text] [Related]
6. Multiphysics Simulation of Local Transport and Absorption Coupled with Pharmacokinetic Modeling of Systemic Exposure of Subcutaneously Injected Drug Solution.
Corpstein CD; Hou P; Park K; Li T
Pharm Res; 2023 Dec; 40(12):2873-2886. PubMed ID: 37344601
[TBL] [Abstract][Full Text] [Related]
7. A Two-Pore Physiologically Based Pharmacokinetic Model to Predict Subcutaneously Administered Different-Size Antibody/Antibody Fragments.
Li Z; Yu X; Li Y; Verma A; Chang HP; Shah DK
AAPS J; 2021 May; 23(3):62. PubMed ID: 33942169
[TBL] [Abstract][Full Text] [Related]
8. Transport and Lymphatic Uptake of Biotherapeutics Through Subcutaneous Injection.
Han D; Rahimi E; Aramideh S; Ardekani AM
J Pharm Sci; 2022 Mar; 111(3):752-768. PubMed ID: 34624293
[TBL] [Abstract][Full Text] [Related]
9. Multiscale pharmacokinetic modeling of systemic exposure of subcutaneously injected biotherapeutics.
Zheng F; Hou P; Corpstein CD; Park K; Li T
J Control Release; 2021 Sep; 337():407-416. PubMed ID: 34324897
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Monoclonal Antibody Disposition after Subcutaneous Administration using a Minimal Physiologically based Pharmacokinetic Model.
Varkhede N; Forrest ML
J Pharm Pharm Sci; 2018; 21(1s):130s-148s. PubMed ID: 30011390
[TBL] [Abstract][Full Text] [Related]
11. Mixed-dimensional multi-scale poroelastic modeling of adipose tissue for subcutaneous injection.
Leng Y; Wang H; de Lucio M; Gomez H
Biomech Model Mechanobiol; 2022 Dec; 21(6):1825-1840. PubMed ID: 36057050
[TBL] [Abstract][Full Text] [Related]
12. Computational modeling of the effect of skin pinch and stretch on subcutaneous injection of monoclonal antibodies using autoinjector devices.
de Lucio M; Leng Y; Wang H; Ardekani AM; Vlachos PP; Shi G; Gomez H
Biomech Model Mechanobiol; 2023 Dec; 22(6):1965-1982. PubMed ID: 37526775
[TBL] [Abstract][Full Text] [Related]
13. Transport and distribution of biotherapeutics in different tissue layers after subcutaneous injection.
Rahimi E; Gomez H; Ardekani AM
Int J Pharm; 2022 Oct; 626():122125. PubMed ID: 35988855
[TBL] [Abstract][Full Text] [Related]
14. Modeling large-volume subcutaneous injection of monoclonal antibodies with anisotropic porohyperelastic models and data-driven tissue layer geometries.
de Lucio M; Leng Y; Hans A; Bilionis I; Brindise M; Ardekani AM; Vlachos PP; Gomez H
J Mech Behav Biomed Mater; 2023 Feb; 138():105602. PubMed ID: 36529050
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous delivery of monoclonal antibodies: How do we get there?
Viola M; Sequeira J; Seiça R; Veiga F; Serra J; Santos AC; Ribeiro AJ
J Control Release; 2018 Sep; 286():301-314. PubMed ID: 30077735
[TBL] [Abstract][Full Text] [Related]
16. Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling.
Hu S; D'Argenio DZ
J Pharmacokinet Pharmacodyn; 2020 Oct; 47(5):385-409. PubMed ID: 32500362
[TBL] [Abstract][Full Text] [Related]
17. Solute Transport across the Lymphatic Vasculature in a Soft Skin Tissue.
Han D; Huang Z; Rahimi E; Ardekani AM
Biology (Basel); 2023 Jun; 12(7):. PubMed ID: 37508373
[TBL] [Abstract][Full Text] [Related]
18. Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies.
Datta-Mannan A; Estwick S; Zhou C; Choi H; Douglass NE; Witcher DR; Lu J; Beidler C; Millican R
MAbs; 2020 Jan; 12(1):1770028. PubMed ID: 32486889
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic modeling of the subcutaneous absorption of therapeutic proteins.
Kagan L
Drug Metab Dispos; 2014 Nov; 42(11):1890-905. PubMed ID: 25122564
[TBL] [Abstract][Full Text] [Related]
20. In vitro model for predicting bioavailability of subcutaneously injected monoclonal antibodies.
Bown HK; Bonn C; Yohe S; Yadav DB; Patapoff TW; Daugherty A; Mrsny RJ
J Control Release; 2018 Mar; 273():13-20. PubMed ID: 29355621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
